Viewing Study NCT03525392


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2025-12-29 @ 10:56 PM
Study NCT ID: NCT03525392
Status: TERMINATED
Last Update Posted: 2023-12-12
First Post: 2018-05-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Sponsor: Ipsen
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D-FR-01087-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators